PADI4 and HLA-DRB1 Are Genetic Risks for Radiographic Progression in RA Patients, Independent of ACPA Status: Results from the IORRA Cohort Study

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Apr 12

PMID 23577190

Citations 25

Authors

Taku Suzuki

Katsunori Ikari

Koichiro Yano

Eisuke Inoue

Yoshiaki Toyama

Atsuo Taniguchi

Hisashi Yamanaka

Shigeki Momohara

Affiliations

Soon will be listed here.

Abstract

Introduction: Rheumatoid arthritis (RA) is a systemic, chronic inflammatory disease influenced by both genetic and environmental factors, leading to joint destruction and functional impairment. Recently, a large-scaled GWAS meta-analysis using more than 37,000 Japanese samples were conducted and 13 RA susceptibility loci were identified. However, it is not clear whether these loci have significant impact on joint destruction or not. This is the first study focused on the 13 loci to investigate independent genetic risk factors for radiographic progression in the first five years from onset of RA.

Methods: Sharp/van der Heijde score of hands at 5-year disease duration, which represents joint damage, were measured retrospectively and used as an outcome variable in 865 Japanese RA patients. Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2). These putative genetic risk factors were assessed by a stepwise multiple regression analysis adjusted for possible non-genetic risk factors: autoantibody positivity (anti-citrullinated peptide antibody [ACPA] and rheumatoid factor), history of smoking, gender and age at disease onset.

Results: The number of SE alleles (P = 0.002) and risk alleles of peptidyl arginine deiminase type IV gene (PADI4, P = 0.04) had significant impact on progressive joint destruction, as well as following non-genetic factors: ACPA positive (P = 0.0006), female sex (P = 0.006) and younger age of onset (P = 0.02).

Conclusions: In the present study, we found that PADI4 risk allele and HLA-DRB1 shared epitope are independent genetic risks for radiographic progression in Japanese rheumatoid arthritis patients. The results of this study give important knowledge of the risks on progressive joint damage in RA patients.

Citing Articles

Autocitrullination confers monocyte chemotactic properties to peptidylarginine deiminase 4.

Yoshida K, Ito H, Kurosaka D, Ikeda R, Noda K, Saito M Sci Rep. 2023; 13(1):7528.

PMID: 37160933 PMC: 10169855. DOI: 10.1038/s41598-023-34469-1.

Heavy Chain Constant Region Usage in Antibodies to Peptidylarginine Deiminase 4 as a Marker of Disease Subsets in Rheumatoid Arthritis.

Gomez-Banuelos E, Shi J, Wang H, Danila M, Bridges Jr S, Giles J Arthritis Rheumatol. 2022; 74(11):1746-1754.

PMID: 35675168 PMC: 9617771. DOI: 10.1002/art.42262.

A genome-wide association study identifying the SNPs predictive of rapid joint destruction in patients with rheumatoid arthritis.

Hayashi S, Matsubara T, Fukuda K, Maeda T, Funahashi K, Hashimoto M Biomed Rep. 2021; 14(3):31.

PMID: 33585033 PMC: 7873586. DOI: 10.3892/br.2021.1407.

Joint Surgery in Tunisian Rheumatoid Arthritis Patients: Prevalence and Risk Factors.

Saidane O, Gafsi L, Ben Tekaya A, Mahmoud I, Tekaya R, Abdelmoula L Arch Rheumatol. 2021; 35(3):426-434.

PMID: 33458667 PMC: 7788662. DOI: 10.46497/ArchRheumatol.2020.7483.

FEATURE SELECTION FOR GENERALIZED VARYING COEFFICIENT MIXED-EFFECT MODELS WITH APPLICATION TO OBESITY GWAS.

Chu W, Li R, Liu J, Reimherr M Ann Appl Stat. 2020; 14(1):276-298.

PMID: 32802245 PMC: 7426018. DOI: 10.1214/19-aoas1310.

References

Rojas-Villarraga A, Diaz F, Calvo-Paramo E, Salazar J, Iglesias-Gamarra A, Mantilla R . Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis. J Autoimmun. 2009; 32(1):64-9. DOI: 10.1016/j.jaut.2008.11.004. View

Singh J, Furst D, Bharat A, Curtis J, Kavanaugh A, Kremer J . 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012; 64(5):625-39. PMC: 4081542. DOI: 10.1002/acr.21641. View

Forslind K, Ahlmen M, Eberhardt K, Hafstrom I, Svensson B . Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis. 2004; 63(9):1090-5. PMC: 1755129. DOI: 10.1136/ard.2003.014233. View

Kobayashi S, Ikari K, Kaneko H, Kochi Y, Yamamoto K, Shimane K . Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population. Arthritis Rheum. 2008; 58(7):1940-6. DOI: 10.1002/art.23494. View

Keystone E . Clinical implications of understanding radiographic findings in relation to clinical outcomes in rheumatoid arthritis. J Rheumatol Suppl. 2009; 82:11-6. DOI: 10.3899/jrheum.090125. View

de Vries-Bouwstra J, Goekoop-Ruiterman Y, Verpoort K, Schreuder G, Ewals J, Terwiel J . Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies. Arthritis Rheum. 2008; 58(5):1293-8. DOI: 10.1002/art.23439. View

Tanaka E, Mannalithara A, Inoue E, Hara M, Tomatsu T, Kamatani N . Efficient management of rheumatoid arthritis significantly reduces long-term functional disability. Ann Rheum Dis. 2007; 67(8):1153-8. DOI: 10.1136/ard.2007.072751. View

Arnett F, Edworthy S, Bloch D, McShane D, Fries J, Cooper N . The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31(3):315-24. DOI: 10.1002/art.1780310302. View

Gorman J, Lum R, Chen J, Suarez-Almazor M, Thomson G, Criswell L . Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum. 2004; 50(2):400-12. DOI: 10.1002/art.20006. View

10.

Kuiper S, van Gestel A, Swinkels H, de Boo T, Da Silva J, van Riel P . Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis. J Rheumatol. 2001; 28(8):1809-16. View

11.

Kang C, Lee H, Ju H, Cho H, Kang C, Bae S . A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum. 2005; 54(1):90-6. DOI: 10.1002/art.21536. View

12.

Nakajima A, Inoue E, Tanaka E, Singh G, Sato E, Hoshi D . Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA. Scand J Rheumatol. 2010; 39(5):360-7. DOI: 10.3109/03009741003604542. View

13.

Cha S, Choi C, Han T, Kang C, Kang C, Bae S . Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis. Arthritis Rheum. 2007; 56(5):1454-63. DOI: 10.1002/art.22570. View

14.

Aletaha D, Funovits J, Breedveld F, Sharp J, Segurado O, Smolen J . Rheumatoid arthritis joint progression in sustained remission is determined by disease activity levels preceding the period of radiographic assessment. Arthritis Rheum. 2009; 60(5):1242-9. DOI: 10.1002/art.24433. View

15.

Stahl E, Raychaudhuri S, Remmers E, Xie G, Eyre S, Thomson B . Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet. 2010; 42(6):508-14. PMC: 4243840. DOI: 10.1038/ng.582. View

16.

Ideguchi H, Ohno S, Hattori H, Senuma A, Ishigatsubo Y . Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs. Arthritis Res Ther. 2006; 8(3):R76. PMC: 1526642. DOI: 10.1186/ar1943. View

17.

van der Heijde D . Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol. 1995; 34 Suppl 2:74-8. View

18.

Wolfe F . The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis. J Rheumatol. 2000; 27(3):630-7. View

19.

Tsukahara S, Shinozaki M, Ikari K, Mochizuki T, Inoue E, Tomatsu T . Effect of matrix metalloproteinase-3 functional SNP on serum matrix metalloproteinase-3 level and outcome measures in Japanese RA patients. Rheumatology (Oxford). 2007; 47(1):41-4. DOI: 10.1093/rheumatology/kem312. View

20.

Yamanaka H, Inoue E, Singh G, Tanaka E, Nakajima A, Taniguchi A . Improvement of disease activity of rheumatoid arthritis patients from 2000 to 2006 in a large observational cohort study IORRA in Japan. Mod Rheumatol. 2007; 17(4):283-9. DOI: 10.1007/s10165-007-0587-6. View